EMVision lands $2.01M grant for first-responder brain scanner
What's the deal? EMVision MedicalDealroom has a profile for this one. Try Dealroom → Devices has secured a US$1.94M non-dilutive grant through Round 19 of the Australian Government's Cooperative Research Centres Projects (CRC-P) programDealroom has a profile for this one. Try Dealroom →. The money will fund development and early clinical validation of its First Responder brain scanner for traumatic brain injury (TBI).
By the numbers: The award ranks in the 91st percentile by size among all grant rounds in Australia, based on a sample of 3,741 deals. It is separate from and additional to a US$1.94M CRC-P grant EMVision received in 2025 for its emu Regional Benefits Study.
What's the endgame? The portable, non-ionising scanner uses the same technology EMVision is already developing for stroke haemorrhage detection. TBI is the company's second clinical indication, adapting the device and its diagnostic algorithms to identify traumatic intracranial haemorrhage.
Why now? EMVision plans to secure its clinical study protocol and ethics approval in the first half of 2027, targeting study initiation in the second half. The project will collect scans from suspected TBI patients in emergency departments, paired with reference CT and MRI imaging, to train and validate detection algorithms.
Why it matters: More than 50 million people sustain a TBI each year worldwide, costing the global economy roughly $400 billion annually. The filing says adding TBI detection should more than double the addressable market for EMVision's planned per-scan consumables model.
What's the scope? The indication extends the scanner beyond hospitals and ambulances to aged care and military settings. Falls are the leading cause of TBI in older adults, while about 22% of personnel evacuated from Iraq and Afghanistan sustained head or neck trauma.
The signal: Australia counts roughly 200,000 TBI events yearly; the US sees about 2.8 million TBI-related emergency visits, hospitalisations, and deaths, plus 800,000 strokes — over 3.5 million time-critical brain emergencies a year. Non-dilutive public funding is letting EMVision widen its device's reach without diluting shareholders.
Read more: kalkinemedia.com
Image credit: "George Washington University Emergency Medical Response Group (EMeRG)" by Lee Cannon, licensed under CC BY-SA 2.0